Both in Pharmaceuticals
Prestige Consumer Healthcare vs Aurinia Pharmaceuticals
Over the past year PBH returned −24.6% and AUPH returned +48.5%; their daily moves had a correlation of 0.02.
PBH −24.6% AUPH +48.5%Growth of $1, one year, split-adjusted
| Metric | PBH | AUPH |
|---|---|---|
| Price | $46.74 | $16.42 |
| Market cap | $2.21B | $2.18B |
| Today | −0.40% | −0.61% |
| 1 month | −10.9% | +0.8% |
| 6 months | −20.1% | +17.5% |
| Year to date | −24.2% | +2.9% |
| 1 year | −25.8% | +25.0% |
| Revenue growth (YoY) | +6.5% | +18.9% |
| Gross margin | 51.3% | 92.1% |
| Net margin | 11.0% | 45.0% |
| P/E (TTM) | 12.9× | 7.0× |
| Price / sales | 2.0× | 7.0× |
| Net cash | -$1.95B | $382.7M |
| Dividend yield | — | — |
| Volatility (60d) | 34.8% | 35.6% |
| Short % of float | 10.3% | 8.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).